CellMed AG is a
BTG International group company
The Business
CellMed is built on a simple business model: to develop and manufacture innovative therapeutic products for patients.
We are leaders in the field of biopolymer science and stem cell biology and are developing therapies that combine both areas of expertise such as our CellBeads™ encapsulated stem cell therapy. We are also developing biopolymer-only products for aesthetic indications and cell therapy delivery, based on more than ten years of experience in the area of biopolymer product development and manufacturing. Our singular focus is to translate our technical expertise and experience into valuable commercial products for patients.
The Vision
Our vision is to provide significant patient benefit by developing and manufacturing potent, customized alginate biopolymer- based products with controllable degradation.
